Network News

Network News, News, Press Releases, Uncategorized

John Theurer Cancer Center Investigators Report Poor Colorectal Cancer Biomarker Testing Rates

Less than half of patients with metastatic tumors have the recommended genomic profiling that forms the basis of precision oncology

Investigators at John Theurer Cancer Center (JTCC) at Hackensack University Medical Center in New Jersey are the first to report poor adherence to genomic profiling guidelines for four biomarkers of metastatic colorectal cancer used to predict response to therapy,

Network News, Press Releases, Uncategorized

John Theurer Cancer Center Investigators Report Effectiveness of New Treatment for Refractory Multiple Myeloma

Triple-drug regimen shown to be superior to conventional treatment in major multicenter study presented at American Society of Hematology annual meeting

Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey were part of the CANDOR global phase III clinical trial for patients with refractory (persistent) multiple myeloma.

Network News, Press Releases

Hackensack Meridian Health, in Partnership with the VNA, NJHCQI and NJ Medicaid Receives $15.8 Million...

Hackensack Meridian Health is honored to announce that it has received an award from the Centers for Medicare and Medicaid Services (CMS) in the amount of $15.8 million to be distributed over seven years to establish the New Jersey Integrated Care for Kids (InCK) Model that will test an Alternative Payment Model (APM) for the Medicaid program supporting multi-sectoral integrated case management and pediatric practice capacity-building in Monmouth and Ocean Counties.